This research investigates therapy-resistant persister cells in lung cancer using single-cell analysis of patient tumors before, during, and after treatment. Findings show persister cells survive by entering a dormant state and activating the cilia–FGFR4 survival pathway. Targeting this pathway could eliminate persister cells and prevent relapse in patients.